Emma Harlan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMO”.

Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMO

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.00102-25

N/A

0DataRank · unranked

1 citations

Monika Żurawska-Kliś, Emma Harlan, Marc H. Scheetz, MIchael N. Neely, Paul R. Yarnold +15 more

Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01766-25

N/A

0DataRank · unranked

1 citations

Marta Zurawska, Adrian Valadez, Emma Harlan, Marc H. Scheetz, Michael Neely +14 more

Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01760-25

N/A

0DataRank · unranked

0 citations

Adrian Valadez, Emma Harlan, Ryan H. Williamson, Marc H. Scheetz, Michael Neely +14 more